Chemical Structure : NVP-BKM120 hydrochloride
CAS No.: 1312445-63-8
货号: PC-44217Not For Human Use, Lab Use Only.
NVP-BKM120 (Buparlisib) hydrochloride potent, selective, orally bioavailable inhibitor of class I PI3K isoforms with IC50 of 52 nM/166 nM/116 nM/262 nM for p110α/β/δ/γ, respectively.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
25 mg | ¥1080 | In stock | |
50 mg | ¥1780 | In stock | |
100 mg | ¥2980 | In stock | |
200 mg | Get quote | ||
1 g | Get quote |
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
NVP-BKM120 (Buparlisib) hydrochloride potent, selective, orally bioavailable inhibitor of class I PI3K isoforms with IC50 of 52 nM/166 nM/116 nM/262 nM for p110α/β/δ/γ, respectively.
NVP-BKM120 (Buparlisib) much less effectively inhibits the class III PI3K Vps34 and mTOR, and has no effect on PI4Kβ and several other kinases.
NVP-BKM120 (Buparlisib) prevents the growth of assorted cancer cell lines when used at 5 μM and inhibits tumor growth in vivo.
分子量 | 446.8545 | |
分子式 | C18H22ClF3N6O2 | |
外观性状 | Solid | |
储存条件 |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
2-Pyridinamine, 5-(2,6-di-4-morpholinyl-4-pyrimidinyl)-4-(trifluoromethyl)-, hydrochloride (1:1) |
1. Maira SM, et al. Mol Cancer Ther. 2012 Feb;11(2):317-28.
2. Pei Y, et al. Cancer Cell. 2012 Feb 14;21(2):155-67.
3. Koul D, et al. Clin Cancer Res. 2012 Jan 1;18(1):184-95.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright